NVO vs TMUS
NVO: A leading global healthcare company pioneering scientific breakthroughs to treat and defeat serious chronic diseases like diabetes and obesity. TMUS: A leading U.S. wireless carrier focused on nationwide 5G network leadership and mobile service delivery.
Side-by-side fundamentals
| Metric | NVO | TMUS | Edge |
|---|---|---|---|
| Price as of 2026-09-09 close | $44.56 | $177.34 | |
| Market cap as of 2026-09-03 | $206.0B | $190.2B | |
| P/E as of 2026-09-03 | 11.40 | 18.55 | NVO lower |
| PEG as of 2026-09-03 | 16.16 | 1.05 | TMUS lower |
| Net margin FY2025, SEC XBRL | +33.1% | +12.4% | NVO higher |
| Gross margin FY2025, SEC XBRL | +81.0% | n/a | |
| Operating margin FY2025, SEC XBRL | +41.3% | +20.7% | NVO higher |
| ROE FY2025, SEC XBRL | +52.8% | +18.6% | NVO higher |
| ROA FY2025, SEC XBRL | +18.9% | +5.0% | NVO higher |
| Debt / equity as of 2026-09-03 | 0.63 | 1.61 | NVO lower |
| Revenue growth (YoY) as of 2026-09-03 | +5.6% | +9.7% | TMUS higher |
| Revenue CAGR (3y) SEC XBRL | +20.4% | +3.5% | NVO higher |
| Dividend yield as of 2026-09-03 | +1.0% | +1.7% | TMUS higher |
| Dividend streak (yrs) SEC XBRL | n/a | 3 | |
| Beta as of 2026-09-03 | 0.84 | 0.16 | |
| 1-year return as of 2026-09-09 close | -17.9% | -26.9% | NVO higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-09-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.